Now let me run calibration searches in parallel.Now I have enough information. Let me write the consolidated meta-review.

---

## Summary
EquiEvo is a co-evolution framework that integrates subequivariant graph neural networks (via learned Local Reference Frame canonicalization) into the joint optimization of robot morphology and behavior policy. It proposes the 3DS-MB benchmark, extending prior co-evolution tasks to variable-direction scenarios (navigation to random goals, competitive sumo), where geometric symmetry is critical. The method consistently outperforms ablation baselines on all proposed tasks and reveals an insightful relationship between task reward structure and evolved morphology symmetry.

---

## Strengths

- **Novel and principled application of subequivariance to co-evolution**: The paper identifies a genuine gap in existing benchmarks—prior tasks use fixed-direction objectives (Table 1) that do not require direction-aware geometric handling—and proposes a concrete remedy via learned LRF canonicalization (Equations 5–12). The argument for why the behavior critic must be equivariant to provide consistent morphology value feedback (Section 3.1, "Invariant of Morphology Value") is technically sound and clearly stated.

- **Learned LRF outperforms hand-crafted alternatives (Figure 7)**: The ablation showing EquiEvo outperforms goal-direction normalization (DN) and heading-direction normalization (HN) across both Ant and Humanoid tasks establishes that the benefit comes from the equivariant architecture itself, not from any ad hoc reference frame construction.

- **Consistent empirical improvements across all tasks**: EquiEvoAnt reaches ~25K reward vs. ~15K for EvoAnt at 100% training (Figure 4a); EquiEvoHumanoid reaches ~35K vs. ~22K for EquiHumanoid (Figure 4b). The four-way ablation design (EquiEvo / Equi / Evo / base) cleanly isolates each component's contribution.

- **Compelling morphology-task mapping analysis (Figures 9–10)**: The paper demonstrates that EquiEvoAnt evolves radially symmetric morphology under the pure navigation reward but shifts to laterally symmetric morphology with stronger front legs when a forward reward is added. This is a genuine scientific insight about the relationship between task structure and evolved morphology.

- **Actor-Critic ablation (Figure 8)** provides actionable design guidance: both actor and critic benefit from equivariance, with actor equivariance being the more critical component.

---

## Weaknesses

### Fatal
None.

### Major

- **No cross-benchmark evaluation on established co-evolution benchmarks**: The entire empirical case rests on the paper's own 3DS-MB tasks. EquiEvo is never evaluated on the forward locomotion tasks used by Transform2Act or the competitive tasks of CompetEvo. Without this, it is impossible to determine whether subequivariance provides broadly useful inductive bias or whether it only helps in direction-sensitive tasks specifically designed to require it. The stated contribution is generality in co-evolution, but the evidence only establishes benefit within the proposed benchmark. This is the single most important gap in the paper.

- **All baselines are component ablations, not independently published systems**: Baselines EquiX, EvoX, and X are defined as variants of EquiEvo itself (Section 4.2). While EvoAnt effectively represents Transform2Act applied to 3DS-MB (it uses the same codebase without equivariance), the paper never explicitly establishes this equivalence or verifies that the EvoX baselines faithfully reproduce published results on tasks where those methods have known performance. This makes it difficult to distinguish "subequivariance helps over the prior art" from "equivariance helps over a non-equivariant variant in direction-sensitive tasks." Combined with the absence of cross-benchmark testing, the claim of superiority over "existing approaches" (Abstract) is overstated.

### Minor

- **Humanoid Navigation skips structural transform**: Section 4.1 states that "we skip the structural transform stage and start directly with the attribute transform" for the Humanoid task. This means the morphology co-evolution for this task is limited to attribute changes (limb lengths, joint torques), with topology fixed. The paper's claim of full "co-evolution of morphology and behavior" is only demonstrated with structural evolution on the Ant Navigation task. This scope limitation should be acknowledged more prominently.

- **Three seeds for high-variance co-evolution experiments**: Section 4.2 explicitly reports 3 seeds. PPO-based co-evolution combines stochastic topology search and policy optimization; 3 seeds is insufficient to rule out run-to-run variance as an explanation for performance gaps, particularly in the Sumo task where win-rate curves show visible fluctuation. No significance tests are reported.

### Trivial

- **Missing computational cost analysis**: The subequivariant GNN $\varphi$ runs at every behavior control step to predict the LRF, adding overhead vs. baselines. Wall-clock training time and sample efficiency normalized by compute are not discussed, which limits practical comparison.

---

## Nice-to-Haves

- Evaluate EquiEvo on the original forward locomotion benchmarks from Transform2Act and competitive tasks from CompetEvo to establish whether subequivariance is a broadly helpful inductive bias or one specifically suited to direction-sensitive tasks.
- Show distribution of evolved morphologies across seeds (rather than a single episode visualization in Figure 10) to demonstrate robustness vs. cherry-picking.
- An ablation separating the LRF subequivariant GNN from the downstream invariant behavior network to clarify whether the gain comes from the learned frame, the invariant behavior representation, or their combination.

---

## Removed Points

*These points are flagged to be removed; treat them with caution.*

- **Critic: "Technical novelty merely applies prior tools"** — While the LRF canonicalization (Han et al., 2024) and subequivariant GNNs (Chen et al., 2023a) are indeed prior work, their integration into a two-layer co-evolution framework with an explicit theoretical argument about morphology value invariance is a nontrivial contribution. Removed as an unfair charge.

- **Critic: Ambiguity between MLP and GraphConv in behavior control** — Section 3.2 says "We use the invariant graph $\mathcal{G}_g$ (such as GraphConv) to perform behavior control. We use a conventional neural network $\varphi_\theta^b$ (such as MLP)." This may reflect parser artifact or parenthetical example syntax, not genuine ambiguity in the method. Removed as a reproducibility nitpick per rules.

- **Strength: "Builds on publicly available codebases"** — Generic observation lacking specific evidence and not tied to a particular claim.

---

## Novel Insights

The morphology-task mapping analysis (Figures 9–10) is the paper's most distinctive scientific contribution: under a symmetric navigation reward (move to any random goal), EquiEvoAnt reliably converges to a radially symmetric morphology, while adding a forward reward breaks this symmetry and produces a laterally structured body with stronger front legs. This directly illustrates that task reward geometry shapes evolved morphology when the learning algorithm respects geometric symmetry—a finding that connects evolutionary biology intuitions (morphology emerges from environmental pressure) to concrete inductive biases in deep RL. Non-equivariant methods fail to exhibit this connection, not because they converge to wrong shapes, but because lower sample efficiency prevents them from fully exploring the morphology space.

---

## Suggestions

1. **Extend evaluation to established benchmarks**: Run EquiEvo on Transform2Act's forward locomotion suite and CompetEvo's competitive tasks. Even showing that EquiEvo does not hurt performance there (i.e., the equivariant design generalizes gracefully) would substantially support the generality claim.
2. **Clarify and emphasize the scope of Humanoid Navigation**: Either add a structural-evolution variant or clearly frame this as an attribute-evolution experiment.
3. **Strengthen statistical reporting**: Report results over 5+ seeds with standard deviations, and if feasible, report p-values for the main navigation comparisons.

---

## Score and Decision

**Calibration anchors used:**
- `/home/wg25r/review_agent/human_reviews/cTR17xl89h.md` — BodyGen, avg 7.5 (Spotlight). Most topically similar: co-evolution with novel mechanism, significant empirical gains. Key difference: BodyGen compared against Transform2Act and others on established benchmarks; this paper does not.
- `/home/wg25r/review_agent/human_reviews/C9uv8qR7RX.md` — SiT, avg 5.67 (Reject). Symmetry-invariant transformers for RL, rejected for insufficient baselines and narrow evaluation. Comparable in scope limitation but SiT had weaker ablations.
- `/home/wg25r/review_agent/human_reviews/VAvSUG3hwI.md` — co-evolution paper, avg 4.67 (Reject). Rejected for weak baselines and missing zero-shot coordination methods; this paper has a cleaner ablation design.
- `/home/wg25r/review_agent/human_reviews/FaL6aTuXod.md` — avg 1.5 (Reject). Circular benchmarking, no substantive contribution. Much weaker than paper under review.

**Positioning**: The paper is clearly above the rejected low-scoring papers (1.5) and above the co-evolution paper with weak baselines (4.67) due to its principled method, thorough ablations, and genuine scientific insight. It is below BodyGen (7.5) because BodyGen validates on established benchmarks and contributes novel mechanisms with theoretical backing. The SiT rejection (5.67) is a fair mid-range anchor; this paper has better ablations than SiT but the same core problem: insufficient breadth of evaluation for the stated generality claims.

Placing the paper at **5.0**: solid motivation, principled method, limited but internally consistent empirical support—but the main claim of generality over existing methods is overstated, and the benchmark is designed around the method's target inductive bias. Leaning reject primarily because the two major weaknesses (no cross-benchmark evaluation, all ablation baselines) prevent the core "outperforms existing approaches" claim from being substantiated.

**Originality**: Moderate — integrates prior equivariance tools into co-evolution; the new benchmark and morphology-task analysis are genuinely novel.  
**Importance**: Moderate-to-good — direction-aware co-evolution is a real gap; practical impact depends on whether results extend beyond 3DS-MB.  
**Claim support**: Weak — within-benchmark results are consistent, but generality claim is unsupported.  
**Experimental soundness**: Moderate — well-designed ablations, limited seeds, no cross-benchmark tests.  
**Writing clarity**: Good — paper is clearly structured and well-motivated.  
**Value to community**: Moderate — the benchmark and morphology-task analysis are useful contributions; wider adoption depends on resolving the generality question.

MY FINAL SCORE: <pineapple>5.0</pineapple>
MY FINAL DECISION: <orange>Reject</orange>